FGF23 and inflammation

por Sharaf El Din, Usama A A, Salem, Mona M, Abdulazim, Dina O
Publicado 2017

Is Fibroblast growth factor 23 the leading cause of increased mortality among chronic kidney disease patients? A narrative review

por Sharaf El Din, Usama A.A., Salem, Mona M., Abdulazim, Dina O.
Publicado 2017

Diabetic nephropathy: Time to withhold development and progression - A review

por Sharaf El Din, Usama A.A., Salem, Mona M., Abdulazim, Dina O.
Publicado 2017

Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review

por Sharaf El Din, Usama A.A., Salem, Mona M., Abdulazim, Dina O.
Publicado 2017

Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients

por Fayed, Ahmed, El Nokeety, Mahmoud M., Heikal, Ahmed A., Abdulazim, Dina O., Naguib, Mervat M.
Publicado 2018

Urine albumin and serum uric acid are important determinants of serum 25 hydroxyvitamin D level in pre-dialysis chronic kidney disease patients

por Fayed, Ahmed, El Nokeety, Mahmoud M., Heikal, Ahmed A., Sadek, Khaled M., Hammad, Hany, Abdulazim, Dina O., Salem, Mona M., Sharaf El Din, Usama A.
Publicado 2019

Is the combination of linagliptin and allopurinol better prophylaxis against post-contrast acute kidney injury? A multicenter prospective randomized controlled study

por Fayed, Ahmed, Hammad, Ahmed A., Abdulazim, Dina O., Hammad, Hany, Amin, Mohamed, Elhadidy, Samir, Salem, Mona M., ElAzim, Ibrahim M. Abd, Zsom, Lajos, Csongradi, Eva, Soliman, Karim M., Sharaf El Din, Usama A.
Publicado 2023